Lihong Du

发表

High turbulence liquid chromatography online extraction and tandem mass spectrometry for the simultaneous determination of suberoylanilide hydroxamic acid and its two metabolites in human serum.

D. Musson, Lihong Du, A. Wang, 2005, Rapid communications in mass spectrometry : RCM.

Reducing glycerophosphocholine lipid matrix interference effects in biological fluid assays by using high-turbulence liquid chromatography.

Robert L. White, Lihong Du, 2008, Rapid communications in mass spectrometry : RCM.

Magnesium sulfate pharmacokinetics after intramuscular dosing in women with preeclampsia

B. Carvalho, O. Oladapo, H. Witjes, 2021, AJOG global reports.

A Study to Determine the Effects of Food and Multiple Dosing on the Pharmacokinetics of Vorinostat Given Orally to Patients with Advanced Cancer

Linda Z. Sun, Linda Z Sun, J. Wagner, 2006, Clinical Cancer Research.

Stability studies of vorinostat and its two metabolites in human plasma, serum and urine.

D. Musson, Lihong Du, A. Wang, 2006, Journal of pharmaceutical and biomedical analysis.

In vivo Protein Interference: Oral Administration of Recombinant Yeast-Mediated Partial Leptin Reduction for Obesity Control

Lihong Du, Baoquan Han, F. Yue, 2022, Frontiers in Microbiology.

Improved partition equilibrium model for predicting analyte response in electrospray ionization mass spectrometry.

Robert L. White, Lihong Du, 2009, Journal of mass spectrometry : JMS.

A flexible and high throughput liquid chromatography-tandem mass spectrometric assay for the quantitation of telcagepant in human plasma.

E. Woolf, C. Miller-Stein, Lihong Du, 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Pharmacokinetics of elbasvir and grazoprevir in subjects with end-stage renal disease or severe renal impairment

Pratik Bhagunde, J. Butterton, D. Panebianco, 2019, European Journal of Clinical Pharmacology.

Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV‐infected children 4 weeks to 18 years of age

H. Teppler, E. Acosta, M. Rizk, 2015, Journal of clinical pharmacology.

803 RELATIONSHIP BETWEEN TRANSAMINASE LEVELS AND PLASMA PHARMACOKINETICS FOLLOWING ADMINISTRATION OF MK-5172 WITH PEGYLATED INTERFERON alfa-2b AND RIBAVIRIN (PR) TO HCV GENOTYPE (G) 1 TREATMENT-NAÏVE PATIENTS

M. Cooreman, L. Wenning, N. Mobashery, 2013 .

Simultaneous determination of clofibrate and its active metabolite clofibric acid in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet absorbance detection.

D. Musson, Lihong Du, Yang Xu, 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Elbasvir/grazoprevir in children aged 3–18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study

M. Pawłowska, M. Jonas, Robert H. Squires, 2023, Hepatology communications.

Randomized Multicenter Study Comparing Safety and Efficacy of Daptomycin Versus Standard-of-care in Pediatric Patients With Staphylococcal Bacteremia

P. Bokesch, J. Bradley, N. Kartsonis, 2018, The Pediatric infectious disease journal.

Alternative Magnesium Sulfate Dosing Regimens for Women With Preeclampsia: A Population Pharmacokinetic Exposure‐Response Modeling and Simulation Study

P. Lumbiganon, L. Duley, B. Carvalho, 2019, Journal of clinical pharmacology.

Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With Preeclampsia

P. Lumbiganon, L. Duley, B. Carvalho, 2018, Journal of clinical pharmacology.

Pharmacokinetic Interactions between the Hepatitis C Virus Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, and Darunavir in Healthy Volunteers

X. Chu, P. Jumes, J. Butterton, 2019, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of elbasvir and grazoprevir in subjects with end-stage renal disease or severe renal impairment

J. Butterton, D. Panebianco, M. Iwamoto, 2019, European Journal of Clinical Pharmacology.

Pharmacokinetic Interactions Between the HCV Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, or Darunavir in Healthy Participants

X. Chu, P. Jumes, J. Butterton, 2019 .